MedPath

A Clinical Trial To Study The Effect Of Kaidaryadi Ghanavati, Nimbatwagadhi Ghanavati, Patolakaturohinyadhi Ghanavati In Non Alcoholic Steato Hepatitis (NASH)

Not Applicable
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2022/10/046784
Lead Sponsor
DR ROHINI HD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

2.Subjects with 1st and 2nd Grade Fatty Liver.

3.Subjects presenting with or without presence clinical features of NASH like Loss of appetite(bhubukshanasha),Fatigue(dourbhalya),Nausea(hrullasa),Vomiting(chardi),Abdominal discomfort /dull aching pain in the right Hypochondriac region (udara shoola).

4.Subjects with or without abnormal Liver Function Test (LFT).

5.Subjects fit for scheduled treatment protocol.

Exclusion Criteria

1.Subjects with H/o Chronic Alcohol Consumption.

2.Subjects with Grade 3 and 4 Fatty Liver.

3.Subjects with T.B, HIV, HBsAg, Obstructive jaundice,Viral hepatitis, Drug induced Hepatitis, end stage liver disease and other systemic disorders.

4.Evidence of moderate to severe Ascities, Fibrosis, Cirrhosis, Splenomegaly, Jaundice, Hepatic Encephalopathy etc.

5.Pregnant women, lactating women and subjects of uncontrolled diabetes with complications.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath